Efficacy and safety of Mirikizumab in the treatment of moderate to severe active ulcerative colitis: a systematic review
Mirikizumab improves clinical, endoscopic, and histological results in ulcerative colitis. This study highlights the clinical importance of Mirikizumab and its potential to change treatment standards for ulcerative colitis.
Authors
- Saurav Misra (ORCID: https://orcid.org/0000-0003-2011-5895)
- Ravi Kant Narayan (ORCID: https://orcid.org/0000-0003-2510-6744)
- Shahnawaz Ahmed (ORCID: https://orcid.org/0000-0001-8339-4137)
- A. K. Shukla (ORCID: https://orcid.org/0000-0002-8157-2267)
Institutions
- Government of West Bengal (IN)
- All India Institute of Medical Sciences Bhopal (IN)
- Kalpana Chawla Government Medical College and Hospital (IN)
- All India Institute of Medical Sciences Bhubaneswar (IN)
Publication Details
- Journal
- Journal of Basic and Clinical Physiology and Pharmacology
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1515/jbcpp-2025-0172
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00